Anticoagulant Tied to Less Bleeding in non-STEMI

February 17, 2015 9:20 PM

8 0

Anticoagulant Tied to Less Bleeding in non-STEMI

Treatment with fondaparinux (Arixtra) was associated with lower rates of major bleeding and death compared with low-molecular-weight heparin in patients with non-ST-segment elevation myocardial infarctions (non-STEMI), researchers reported.

In review of data from a Swedish registry, among non-STEMI patients treated with injections with the factor Xa inhibitor, 1.1% experienced bleeding events during hospitalization compared with 1.8% of those treated with low-molecular-weight heparin (LMWH), wrote Karolina Szummer, MD, PhD, of Karolins...

Also read: Synergy Pharma's irritable bowel drug succeeds in key study

Read more

To category page

Loading...